NEW YORK, April 20 (GenomeWeb News) - Strategic Diagnostics will provide Genomic Antibodies' antibodies to Berlex as part of an amendment of its supply agreement with the drug maker, the companies said today in a statement.

Genomic Antibodies' process will reduce the time it takes to produce antibodies for Berlex, Matthew Knight, Strategic Diagnostics president and CEO, said in the statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.